Fig. 6From: Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in miceMolecular docking and validation of related protein results. A Protein spatial structure and drug structure; SCH may regulated SGK1 protein at 250 site; B Amino acid sequence for SGK1 protein; C Schematic diagram of protein mutation; D SCH suppressed NLRP3 inflammasone in vivo and vitro model of colitis; E Relative expressionBack to article page